<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="756">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151315</url>
  </required_header>
  <id_info>
    <org_study_id>119937</org_study_id>
    <nct_id>NCT05151315</nct_id>
  </id_info>
  <brief_title>NitrX Total Knee Arthroplasty RSA</brief_title>
  <official_title>Component Migration, Polyethylene Wear, and Joint Inflammation of the Evolution Versus Evolution NitrX Total Knee Arthroplasty System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MicroPort Orthopedics Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metal hypersensitivity is a recognized complication in some patients following total joint&#xD;
      arthroplasty. This can result in a reaction to metal particles from the implants placed in&#xD;
      the joint and cause tissue injury. The Evolution® NitrX™ (MicroPort Orthopaedics, Memphis,&#xD;
      TN) knee implant was designed with the addition of a coating meant to create a barrier&#xD;
      against the release of metal ions. The primary purpose of this study is to compare the&#xD;
      Evolution and Evolution NitrX implant (implants your surgeon uses in total knee arthroplasty&#xD;
      surgery). This study will compare the stability of these knee implants (any movement the&#xD;
      implant makes after surgery) through the use of specialized xrays, called &quot;radiostereometric&#xD;
      analysis&quot; (RSA for short). The investigators will also compare levels of circulating metal&#xD;
      particles with blood draws and the effects of any circulating metal with MR imaging. The&#xD;
      investigators will also be looking at the participants clinical outcomes using joint function&#xD;
      and patient satisfaction questionnaires. A total of 50 patients will be enrolled into the&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant Migration (Tibial Component)</measure>
    <time_frame>2 years</time_frame>
    <description>Model based Radiostereometric Analysis (RSA, specialized Xrays) will be used to register the location of the tibial implant components during supine and standing exams and measure implant movement. Changes throughout the different time points of potential tibial migration, with the use of the tibial bone beads, will be measured in millimeters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant Migration (Femoral Component)</measure>
    <time_frame>2 years</time_frame>
    <description>Model based Radiostereometric Analysis (specialized Xrays) will be used to register the location of the femoral components during supine and standing exams and measure implant movement. Changes throughout the different time points of potential femoral migration, with the use of the femoral bone beads, will be measured in millimeters.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Wear Rates</measure>
    <time_frame>2 weeks (baseline), 6 weeks, 3 months, 6 months, 1 year, and 2 years.</time_frame>
    <description>Model based Radiostereometric Analysis (specialized Xrays) will be used to register the location of the femoral and tibial components in both standing and supine exams where the minimum joint space width between components on the medial and lateral condyles can be calculated as a measurement (in millimeters) of polyethylene wear.</description>
  </other_outcome>
  <other_outcome>
    <measure>Circulating metal levels</measure>
    <time_frame>Pre-operative, 1 and 2 years post-operatively.</time_frame>
    <description>Patients will have blood drawn and the levels of circulating cobalt, chromium, and nickel will be measured in whole blood. One vial of blood will be drawn from the patient (in milliliters).</description>
  </other_outcome>
  <other_outcome>
    <measure>Synovial Joint Inflammation observation</measure>
    <time_frame>2 Years</time_frame>
    <description>Patients will complete an MRI exam using metal artefact reduction sequences. Scans will be evaluated and scored for synovial inflammation and fibrosis, indicative of reactions to metal debris, and the presence of fibrous tissue at the bone-cement-implant interface, indicative of component loosening.</description>
  </other_outcome>
  <other_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome score (KOOS)</measure>
    <time_frame>Pre-operative, 3 months, 1 year, and 2 year post-operative</time_frame>
    <description>Patient reported outcome measure. Holds 42 items that asks patient about pain, functional daily living, and sport and recreation. Questionnaire measures levels in frequency (never to always) and severity (none to extreme). Scores are from 0-100, with higher scores indicating no knee problems.</description>
  </other_outcome>
  <other_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>Pre-operative, 3 months, 1 year, and 2 year post-operative</time_frame>
    <description>Patient reported outcome measure observing the ability of a patient to forget about a joint due to successful treatment. Contains 12 items with frequency level measurement (never to mostly). The higher the score (0-100), the less aware the patient is of their affected joint when performing daily activity.</description>
  </other_outcome>
  <other_outcome>
    <measure>Veterans-Rand 12 Item Health Survey (VR-12)</measure>
    <time_frame>Pre-operative, 3 months, 1 year, and 2 year post-operative</time_frame>
    <description>Patient reported outcome measure observing physical and mental health status of patient. Contains 14 items measuring levels of severity (excellent to poor) and frequency (None of the time to Yes, all of the time). Higher scores indicate higher quality of life and vice versa.</description>
  </other_outcome>
  <other_outcome>
    <measure>European Quality of Life - 5 Dimension (EQ-5D)</measure>
    <time_frame>Pre-operative, 3 months, 1 year, and 2 year</time_frame>
    <description>Patient reported outcome measure. Standardized 5 item instrument measuring generic health status of patient. The EQ5D uses a Likert scale which assesses five states (mobility, self care, usual care, pain and discomfort and anxiety and depression) at five different levels - none(0), slight(1), moderate(2), severe(3) or unable to perform(5). Levels are coded 1-5 and an index score is then generated. Higher scores indicate higher health status of patient.</description>
  </other_outcome>
  <other_outcome>
    <measure>Metal Exposure/Sensitivity</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Patient reported outcome measure. Screening tool for noting pre-operative environmental metal exposures. Questionnaire contains Yes or No questions. Higher scores would indicate greater exposure and/or metal sensitivity.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Knee Osteoarthritis</condition>
  <condition>Radiostereometric Analysis</condition>
  <arm_group>
    <arm_group_label>Evolution Total Knee Arthroplasty system</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will undergo total knee arthroplasty with the Evolution Total Knee System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Evolution with NitrX Total Knee Arthoplasty system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo total knee arthroplasty with the NitrX Evolution Total Knee System which has the specialized protective coating</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Knee Arthroplasty with Evolution® NitrX™ Knee System</intervention_name>
    <description>Patients will receive cemented Evolution knee system with NitrX coating for their total knee arthroplasty.</description>
    <arm_group_label>Evolution with NitrX Total Knee Arthoplasty system</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Knee Arthroplasty with Evolution Knee System</intervention_name>
    <description>Patients will receive cemented Evolution knee system without NitrX coating for their total knee arthroplasty.</description>
    <arm_group_label>Evolution Total Knee Arthroplasty system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty&#xD;
&#xD;
          -  Varus knee deformity of 0 to 10 degrees&#xD;
&#xD;
          -  Sufficient ligamentous function to warrant retention of the posterior cruciate&#xD;
             ligament&#xD;
&#xD;
          -  Between ages of 21 and 80 inclusive&#xD;
&#xD;
          -  Patients willing and able to comply with follow-up requirements and self-evaluations&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
          -  No contraindications to Magnetic Resonance Imaging (MRI)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active or previous infection&#xD;
&#xD;
          -  Medical condition precluding major surgery&#xD;
&#xD;
          -  Inflammatory arthropathy&#xD;
&#xD;
          -  Prior Patellectomy&#xD;
&#xD;
          -  PCL deficiency&#xD;
&#xD;
          -  Major Coronal plane deformity&#xD;
&#xD;
          -  Valgus deformity&#xD;
&#xD;
          -  Bone defects requiring augments, cones and/or stemmed implants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward M Vasarhelyi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Sciences Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthew Teeter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Science Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lyndsay Somerville, PhD</last_name>
    <phone>519 685 8500</phone>
    <phone_ext>36645</phone_ext>
    <email>lyndsay.somerville@lhsc.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janel Dhooma, MPH</last_name>
    <phone>519 685 8500</phone>
    <phone_ext>32794</phone_ext>
    <email>janel.dhooma@lhsc.on.ca</email>
  </overall_contact_backup>
  <reference>
    <citation>Pijls BG, Plevier JWM, Nelissen RGHH. RSA migration of total knee replacements. Acta Orthop. 2018 Jun;89(3):320-328. doi: 10.1080/17453674.2018.1443635. Epub 2018 Mar 6.</citation>
    <PMID>29508661</PMID>
  </reference>
  <reference>
    <citation>Teeter MG, Marsh JD, Howard JL, Yuan X, Vasarhelyi EM, McCalden RW, Naudie DDR. A randomized controlled trial investigating the value of patient-specific instrumentation for total knee arthroplasty in the Canadian healthcare system. Bone Joint J. 2019 May;101-B(5):565-572. doi: 10.1302/0301-620X.101B5.BJJ-2018-1323.R1.</citation>
    <PMID>31038991</PMID>
  </reference>
  <reference>
    <citation>Teeter MG, Thoren J, Yuan X, McCalden RW, MacDonald SJ, Lanting BA, Naudie DD. Migration of a cemented fixed-bearing, polished titanium tibial baseplate (Genesis II) at ten years : a radiostereometric analysis. Bone Joint J. 2016 May;98-B(5):616-21. doi: 10.1302/0301-620X.98B5.36865.</citation>
    <PMID>27143731</PMID>
  </reference>
  <reference>
    <citation>Teeter MG, Perry K, Yuan X, Howard JL, Lanting BA. The Effects of Resection Technique on Implant Migration in Single Radius Posterior-Stabilized Total Knee Replacement. J Knee Surg. 2020 Jan;33(1):78-83. doi: 10.1055/s-0038-1676462. Epub 2018 Dec 18.</citation>
    <PMID>30562833</PMID>
  </reference>
  <reference>
    <citation>Sealed Envelope Ltd.2012.Power calculator for continuous outcome non0-inferiority trial.[Online] Available from: https://www.sealedenvelope.com/power/continuous-noninferios/[Accessed Thu Jan 14 2021].</citation>
  </reference>
  <reference>
    <citation>van Ijsseldijk EA, Valstar ER, Stoel BC, de Ridder R, Nelissen RG, Kaptein BL. Measuring polyethylene wear in total knee arthroplasty by RSA: differences between weight-bearing and non-weight-bearing positioning. J Orthop Res. 2014 Apr;32(4):613-7. doi: 10.1002/jor.22579. Epub 2014 Jan 7.</citation>
    <PMID>24395396</PMID>
  </reference>
  <reference>
    <citation>Teeter MG, Wihlidal J, McCalden RW, Yuan X, MacDonald SJ, Lanting BA, Naudie DD. Radiostereometric Analysis Permits In Vivo Measurement of Very Small Levels of Wear in TKA. Clin Orthop Relat Res. 2019 Jan;477(1):80-90. doi: 10.1097/CORR.0000000000000399.</citation>
    <PMID>30794231</PMID>
  </reference>
  <reference>
    <citation>Gascoyne T, Parashin S, Teeter M, Bohm E, Laende E, Dunbar M, Turgeon T. In vivo wear measurement in a modern total knee arthroplasty with model-based radiostereometric analysis. Bone Joint J. 2019 Nov;101-B(11):1348-1355. doi: 10.1302/0301-620X.101B11.BJJ-2018-1447.R2.</citation>
    <PMID>31674253</PMID>
  </reference>
  <reference>
    <citation>Koff MF, Burge AJ, Potter HG. Clinical magnetic resonance imaging of arthroplasty at 1.5 T. J Orthop Res. 2020 Jul;38(7):1455-1464. doi: 10.1002/jor.24606. Epub 2020 Feb 4. Review.</citation>
    <PMID>31975444</PMID>
  </reference>
  <reference>
    <citation>Attard V, Li CY, Self A, Mann DA, Borthwick LA, O'Connor P, Deehan DJ, Kalson NS. Quantification of intra-articular fibrosis in patients with stiff knee arthroplasties using metal-reduction MRI. Bone Joint J. 2020 Oct;102-B(10):1331-1340. doi: 10.1302/0301-620X.102B10.BJJ-2020-0841.R1.</citation>
    <PMID>32993344</PMID>
  </reference>
  <reference>
    <citation>Heyse TJ, Chong le R, Davis J, Boettner F, Haas SB, Potter HG. MRI analysis of the component-bone interface after TKA. Knee. 2012 Aug;19(4):290-4. doi: 10.1016/j.knee.2011.05.011. Epub 2011 Jul 8.</citation>
    <PMID>21741843</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 25, 2021</last_update_submitted>
  <last_update_submitted_qc>November 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Brent Lanting</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

